Copay Accumulator Rule Not In Trump’s Unified Agenda

By Luke Zarzecki / September 25, 2025 at 12:41 PM

The Trump administration did not include in its Unified Agenda published earlier in September a Biden administration rule that would have addressed whether drug manufacturer cost assistance should count towards to a patient’s annual cost sharing limits, and HHS did not respond to questions on whether the agency plans to include the provision in the Notice of Benefit Payment Parameters rule.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.